DELANEY FROEBEL: Open Payments
NPI 1376273946 · OLEAN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,490 in 147 payments from 25 companies in 2025. Trend: 2023 $1,132 · 2024 $2,282 · 2025 $2,490
Food & beverage: $2,490
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 39 | $543 |
| AstraZeneca Pharmaceuticals LP | 18 | $379 |
| Lilly USA, LLC | 14 | $265 |
| Novo Nordisk Inc | 12 | $246 |
| GlaxoSmithKline, LLC. | 23 | $215 |
| Paratek Pharmaceuticals, Inc. | 7 | $154 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| Exact Sciences Corporation | 2 | $46 |
Products named: GEMTESA, FARXIGA, Ozempic, TRELEGY ELLIPTA, MOUNJARO, JARDIANCE, NUZYRA, Kerendia.
Industry payments across NY — which companies pay providers there.
